Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects

Expert Opinion on Investigational Drugs
Chun-Su Yuan, Robert J Israel

Abstract

Methylnaltrexone is an investigational peripheral opioid receptor antagonist, a quaternary derivative of naltrexone. Methylnaltrexone has greater polarity and lower lipid solubility, thus it does not cross the blood-brain barrier in humans. Methylnaltrexone offers the therapeutic potential to block or reverse the undesired side effects of opioids that are mediated by receptors located in the periphery (e.g., in the gastrointestinal tract), without affecting analgesia or precipitating the opioid withdrawal symptoms that are predominantly mediated by receptors in the CNS. This article reviews preclinical studies and clinical opioid bowel dysfunction trial data, and briefly discusses other potential roles of this compound in clinical practice.

References

Aug 1, 1992·Journal of Pain and Symptom Management·P Glare, J N Lickiss
Jul 1, 1992·Clinical Pharmacology and Therapeutics·J A Culpepper-MorganM J Kreek
May 1, 1989·Anesthesiology·J H LevyB F Walker
Oct 1, 1989·Nursing·M McCaffrey, A Beebe
Nov 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A N KotakeL I Goldberg
Mar 1, 1985·Neuropharmacology·D R Brown, L I Goldberg
Mar 1, 1988·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J D GowanJ Kitts
Jan 1, 1985·Annual Review of Pharmacology and Toxicology·L Manara, A Bianchetti
Nov 1, 1982·British Journal of Anaesthesia·T K PetersenM Wernberg
Mar 12, 1982·European Journal of Pharmacology·J RussellH Merz
Jan 1, 1993·Life Sciences·K E Barke, L B Hough
Aug 1, 1993·Journal of Clinical Pharmacology·J F FossL I Goldberg
Aug 1, 1995·Drug and Alcohol Dependence·L J CheskinJ H Jaffe
Aug 1, 1997·Annals of Internal Medicine·D E MeierC K Cassel
Nov 14, 1997·Anesthesiology·D B MurphyM B Murphy
Jun 4, 1998·Journal of Neuroimmunology·T K Eisenstein, M E Hilburger
Nov 10, 1998·Journal of Clinical Pharmacology·C S YuanM F Roizen
Nov 24, 1998·Journal of Clinical Pharmacology·C S YuanJ Moss
Jan 27, 2000·JAMA : the Journal of the American Medical Association·C S YuanM F Roizen
Jun 22, 2000·Annals of Surgery·L BasseH Kehlet
Jul 26, 2000·Diseases of the Colon and Rectum·A HugeE C Jehle
Sep 16, 2000·JAMA : the Journal of the American Medical Association·C S Yuan, J F Foss
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·Chun-Su YuanJoachim Osinski
Aug 29, 2002·Alimentary Pharmacology & Therapeutics·N D HawkesG A O Thomas
Oct 29, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Joachim OsinskiChun-Su Yuan
Jun 5, 2003·Biochemical Pharmacology·Gang WeiChun Su Yuan
Oct 16, 2003·The Journal of Pharmacology and Experimental Therapeutics·Wen-Zhe HoJonathan Moss
Mar 27, 2004·Life Sciences·Han H AungChun-Su Yuan
Sep 11, 2004·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A J Bauer, G E Boeckxstaens

❮ Previous
Next ❯

Citations

Jan 31, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Laura AnselmiCatia Sternini
Jun 1, 2011·Current Gastroenterology Reports·Kirk A CaddellKeith Miller
Feb 1, 2008·Current Treatment Options in Gastroenterology·Howard Y Chang, Anthony J Lembo
Mar 31, 2007·American Journal of Respiratory Cell and Molecular Biology·Patrick A SingletonJoe G N Garcia
Mar 19, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Vishvarani WanigasekeraIrene Tracey
Mar 15, 2012·Clinical Drug Investigation·Antonio Gatti, Alessandro Fabrizio Sabato
Dec 26, 2012·Expert Review of Gastroenterology & Hepatology·Sabine BaderGerhild Becker
Jan 25, 2007·Expert Opinion on Investigational Drugs·Peter Holzer
Oct 19, 2010·Gastroenterology Clinics of North America·Siddharth Singh, Satish S C Rao
Apr 7, 2009·Regulatory Peptides·Peter Holzer
Oct 16, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Michael K Herbert, Peter Holzer
Oct 9, 2007·ChemMedChem·Allan J GoodmanRoland E Dolle
Jan 23, 2010·Anaesthesia·V Mehta
Aug 29, 2006·Current Opinion in Pharmacology·Laura M Bohn, Kirsten M Raehal
Dec 29, 2010·The American Journal of Hospice & Palliative Care·Youssef RezkHoward S Smith
Feb 2, 2008·Bulletin of Experimental Biology and Medicine·S K SudakovI A Pomytkin
Jun 15, 2010·Current Opinion in Anaesthesiology·Peter Holzer
Sep 11, 2014·Natural Product Reports·Mark S ButlerMatthew A Cooper
Mar 13, 2013·Current Opinion in Supportive and Palliative Care·Katri E ClemensGerd Mikus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Expert Opinion on Investigational Drugs
Paul Neary, Conor P Delaney
Expert Opinion on Investigational Drugs
Peter Holzer
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
A N KotakeL I Goldberg
© 2022 Meta ULC. All rights reserved